drugset / Trial / NCT05416125
Vyvanse in Children Aged 6 to 12 Years
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will randomize children who have difficulty maintaining a healthy weight to one of two treatment groups: lifestyle therapy plus lisdexamfetamine or lifestyle therapy plus placebo.
Timeline
- Start
- 2023-12-20
- Primary completion
- 2026-06-23
- Completion
- 2026-06-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lisdexamfetamine Dimesylate | Small molecule | — | — |